- US-listed companies
- Merck & Co., Inc.
- Income statement
Merck & Co., Inc.MRK
Market cap
$245.1B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 45,987 | 48,047 | 47,267 | 44,033 | 42,237 | 39,498 | 39,807 | 40,122 | 42,294 | 46,840 | 47,994 | 48,704 | 59,283 | 60,115 | 64,168 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | 18,396 | 16,871 | 16,446 | 16,954 | 16,768 | 14,934 | 13,891 | 12,775 | 13,509 | 14,112 | 15,485 | 13,626 | 17,411 | 16,126 | 15,193 |
| Research & development | 10,991 | 8,467 | 8,168 | 7,503 | 7,180 | 6,704 | 10,124 | 10,208 | 9,752 | 9,872 | 13,558 | 12,245 | 13,548 | 30,531 | 17,938 |
| Selling, general & administrative | 13,245 | 13,733 | 12,776 | 11,911 | 11,606 | 10,313 | 9,762 | 9,830 | 10,102 | 10,615 | 10,468 | 9,634 | 10,042 | 10,504 | 10,816 |
| Income before tax | - | 7,334 | 8,739 | 5,545 | 17,283 | 5,401 | 4,659 | 6,521 | 8,701 | 11,464 | 8,791 | 13,879 | 16,444 | 1,889 | 19,936 |
| Pretax margin (%) | - | 15.3 | 18.5 | 12.6 | 40.9 | 13.7 | 11.7 | 16.3 | 20.6 | 24.5 | 18.3 | 28.5 | 27.7 | 3.1 | 31.1 |
| Provision for income taxes | 671 | 942 | 2,440 | 1,028 | 5,349 | 942 | 718 | 4,103 | 2,508 | 1,687 | 1,709 | 1,521 | 1,918 | 1,512 | 2,803 |
| Effective tax rate (%) | - | ||||||||||||||
| Net income | 982 | 6,392 | 6,299 | 4,517 | 11,934 | 4,459 | 3,941 | 2,418 | 6,220 | 9,843 | 7,082 | 13,049 | 14,519 | 365 | 17,133 |
| Net income margin (%) | |||||||||||||||
| Earnings per share | 0.28 | 2.04 | 2.03 | 1.49 | 4.12 | 1.58 | 1.42 | 0.88 | 2.34 | 3.84 | 2.79 | 5.16 | 5.73 | 0.14 | 6.76 |
| Diluted EPS | 0.28 | 2.02 | 2 | 1.47 | 4.07 | 1.56 | 1.41 | 0.87 | 2.32 | 3.81 | 2.78 | 5.14 | 5.71 | 0.14 | 6.74 |
| Dividend payout ratio (%) | |||||||||||||||
| Dividend per share | 1.52 | 1.56 | 1.69 | 1.73 | 1.77 | 1.81 | 1.85 | 1.89 | 1.99 | 2.26 | 2.48 | 2.64 | 2.8 | 2.96 | 3.12 |